Stocks of the Hour: Proteomics International Laboratories, Aurumin, Forrestania Resources
To register for today’s webinar click here. Proteomics International Laboratories (ASX:PIQ), a pioneer in predictive diagnostics, announced groundbreaking results showing the PromarkerD predictive test can predict renal decline in type 1 diabetes. PromarkerD has been previously validated for predicting renal decline up to four years in advance in type 2 diabetes. Shares are trading 8.98 […]